Obesity pillars

Satisfaction and experience with once-weekly tirzepatide treatment from doctors and people with obesity or overweight

Updated

Abstract

Real-world evidence on treatment satisfaction with tirzepatide among people with obesity or overweight is limited.

  • Tirzepatide is a medication that targets specific receptors to help manage weight.
  • The study focuses on individuals with obesity or overweight who do not have type 2 diabetes.
  • Treatment patterns and satisfaction levels among patients and their physicians are assessed.
  • Findings contribute to understanding the experiences of patients using tirzepatide in a real-world setting.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Theresa Hunter Gibble, Claire Gerber, Sonya Kokil Raikar, Era Seth, and Esther Artime are employees and stockholders of Eli Lilly and Company, Indianapolis, United States. Andrea Leith, Lewis Harrison are employees of Adelphi Real World, Bollington, UK.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free